These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15690608)

  • 1. Metabolic disturbances in liver 1H MR spectroscopy in HIV and HCV co-infected patients as a potential marker of hepatocyte activation.
    Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Siergiejczyk L; Orzechowska-Bobkiewicz A; Prokopowicz D; Walecki J
    Acta Radiol; 2004 Dec; 45(8):803-9. PubMed ID: 15690608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proton magnetic resonance spectroscopy in the liver of HIV and HCV coinfected patients].
    Wiercińska-Drapało A; Tarasów E; Lapiński TW
    Przegl Epidemiol; 2005; 59(2):447-53. PubMed ID: 16190553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.
    Cho SG; Kim MY; Kim HJ; Kim YS; Choi W; Shin SH; Hong KC; Kim YB; Lee JH; Suh CH
    Radiology; 2001 Dec; 221(3):740-6. PubMed ID: 11719670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR proton spectroscopy in liver examinations of healthy individuals in vivo.
    Tarasów E; Siergiejczyk L; Panasiuk A; Kubas B; Dzienis W; Prokopowicz D; Walecki J
    Med Sci Monit; 2002 Feb; 8(2):MT36-40. PubMed ID: 11859290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profile of liver damage in non-cirrhotic virus C and autoimmune hepatitis: A proton decoupled
    Hakkarainen A; Puustinen L; Kivisaari R; Boyd S; Nieminen U; Arkkila P; Lundbom N
    Eur J Radiol; 2017 May; 90():205-211. PubMed ID: 28583636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus and hepatitis C virus co-infection.
    Vlahakis SR
    J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
    Jones M; Núñez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hepatitis C viral response after initiation of highly active antiretroviral therapy and control of HIV viremia in chronically co-infected individuals.
    Kottilil S; Jagannatha S; Lu A; Liu S; McLaughlin M; Metcalf JA; Dewar R; Campbell C; Koratich C; Maldarelli F; Masur H; Polis MA
    HIV Clin Trials; 2004; 5(1):25-32. PubMed ID: 15002084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and hepatitis C virus co-infection.
    Rockstroh JK; Spengler U
    Lancet Infect Dis; 2004 Jul; 4(7):437-44. PubMed ID: 15219554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV co-infection is associated with metabolic abnormalities among HAART naive HIV-infected persons.
    Kuti MA; Akinyemi JO; Ogunbosi BO; Kuti KM; Adesina OA; Awolude OA; Michael OS; Adewole IF
    Niger J Clin Pract; 2017 Jul; 20(7):799-803. PubMed ID: 28791972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver histopathology in human immunodeficiency virus-hepatitis C virus co-infected patients with fatal liver disease.
    Lichterfeld M; Haas S; Fischer HP; Voigt E; Rockstroh JK; Spengler U
    J Gastroenterol Hepatol; 2005 May; 20(5):739-45. PubMed ID: 15853988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
    Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
    Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.
    Stapleton JT; Bennett K; Bosch RJ; Polgreen PM; Swindells S
    HIV Clin Trials; 2007; 8(6):429-36. PubMed ID: 18042508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.
    Li Vecchi V; Soresi M; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; Terranova A; Vizzini G; Montalto G
    Int J Infect Dis; 2012 May; 16(5):e397-402. PubMed ID: 22425495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.